Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic ...

Recent findings reveal that induced satellite cells can effectively regenerate muscle tissue, outperforming traditional ...

Oxford Biomedica plc ( OTCPK:OXBDF) Q2 2024 Earnings Conference Call September 23, 2024 8:00 AM ET Frank Mathias - Chief Executive Officer Sebastien Ribault - Chief Business Officer Lucinda Crabtree - ...

Co-expressing NPY and its inhibitory receptor Y2 in excitatory hippocampal cells allows inhibitory autoregulation of ...

Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is implementing a restructuring intended to optimize the Company’s cost structure ...

Inc. (Nasdaq: BLUE) today announced that it has completed the restatement of its consolidated financial statements for the ...

Proteomic analysis of tunneling nanotubes (TNTs) identifies CD9 and CD81 as major positive regulators of TNT formation.

A model with a mixture of three different decision strategies is developed to characterize several atypical behavioral patterns of individuals with depression and anxiety in an uncertain reward ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report) today. The company’s ...

RPE-1 cells adapt to aneuploidy in vitro, a process characterized by reduced CIN and inflammation. This study shows that this ...